[ADAM17 knockdown increases sensitivity of SW480 cells to cetuximad].

CONCLUSIONS: ADAM17 knockdown obviously inhibits EGFR-AKT signaling pathway and increases the sensitivity of SW480 cells to tocetuximad.
PMID: 30514687 [PubMed - in process]

Source: Journal of Southern Medical University - November 30, 2018 Category: Universities & Medical Training Authors: Chen Y, Zheng K, Chen Z, Feng H, Fang W, Huang Z Tags: Nan Fang Yi Ke Da Xue Xue Bao Source Type: research